In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.

Modelling of in vitro human serum albumin (HSA) binding data of 94 diverse drugs and drug-like compounds is performed to develop global predictive models that are applicable to the whole medicinal chemistry space. For this aim, ant colony systems, a stochastic method along with multiple linear regression (MLR), is employed to exhaustively search and select multivariate linear equations, from a pool of 327 molecular descriptors. This methodology helped us to derive optimal quantitative structure-property relationship (QSPR) models based on five and six descriptors with excellent predictive power. The best five-descriptor model is based on Kier and Hall valence connectivity index--Order 5 (path), Auto-correlation descriptor (Broto-Moreau) weighted by atomic masses--Order 4, Auto-correlation descriptor (Broto-Moreau) weighted by atomic polarizabilities--Order 5, AlogP98, SklogS (calculated buffer water solubility) [R=0.8942, Q=0.86790, F=62.24 and SE=0.2626]; the best six-variable model is based on Kier and Hall valence connectivity index of Order 3 (cluster), Auto-correlation descriptor (Broto-Moreau) weighted by atomic masses--Order 4, Auto-correlation descriptor (Broto-Moreau) weighted by atomic polarizabilities--Order 5, Atomic-Level-Based AI topological descriptors--AIdsCH, AlogP98, SklogS (calculated buffer water solubility) [R=0.9128, Q=0.89220, F=64.09 and SE=0.2411]. From the analysis of the physical meaning of the selected descriptors, it is inferred that the binding affinity of small organic compounds to human serum albumin is principally dependent on the following fundamental properties: (1) hydrophobic interactions, (2) solubility, (3) size and (4) shape. Finally, as the models reported herein are based on computed properties, they appear to be a valuable tool in virtual screening, where selection and prioritisation of candidates is required.

[1]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[2]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[3]  Jürgen Bajorath,et al.  Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.

[4]  G. Sudlow,et al.  The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.

[5]  Ramamurthi Narayanan,et al.  In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.

[6]  David J. Begley,et al.  Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood−Brain Barrier , 1998, Pharmaceutical Research.

[7]  D. E. Clark,et al.  Progress in computational methods for the prediction of ADMET properties. , 2002, Current opinion in drug discovery & development.

[8]  Milan Randic,et al.  On Interpretation of Well-Known Topological Indices , 2001, J. Chem. Inf. Comput. Sci..

[9]  Roman Kaliszan,et al.  Quantitative structure-enationselective retention relationships for the chromatography of 1,4-benzodiazepines on a human serum albumin based HPLC chiral stationary phase: An approach to the computational prediction of retention and enantioselectivity , 1992 .

[10]  Tingjun Hou,et al.  Recent development and application of virtual screening in drug discovery: an overview. , 2004, Current pharmaceutical design.

[11]  Shu-Shen Liu,et al.  VSMP: A Novel Variable Selection and Modeling Method Based on the Prediction , 2003, J. Chem. Inf. Comput. Sci..

[12]  M Dorigo,et al.  Ant colonies for the travelling salesman problem. , 1997, Bio Systems.

[13]  H. Vorum.  Reversible ligand binding to human serum albumin. Theoretical and clinical aspects. , 1999, Danish medical bulletin.

[14]  Michael H Abraham,et al.  The factors that influence permeation across the blood-brain barrier. , 2004, European journal of medicinal chemistry.

[15]  J. Topliss,et al.  Unified model for the corneal permeability of related and diverse compounds with respect to their physicochemical properties. , 1996, Journal of pharmaceutical sciences.

[16]  Roald Hoffmann,et al.  QUALITATIVE THINKING IN THE AGE OF MODERN COMPUTATIONAL CHEMISTRY : OR WHAT LIONEL SALEM KNOWS , 1998 .

[17]  V. Andrisano,et al.  Enantioselective separation of chiral arylcarboxylic acids on an immobilized human serum albumin chiral stationary phase. , 1997, Chirality.

[18]  Gabriele Cruciani,et al.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.

[19]  Andreas Zell,et al.  Feature Selection for Descriptor Based Classification Models. 2. Human Intestinal Absorption (HIA) , 2004, J. Chem. Inf. Model..

[20]  Tudor I. Oprea,et al.  Virtual Screening in Lead Discovery: A Viewpoint† , 2002, Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry.

[21]  Lemont B. Kier,et al.  Modeling Blood-Brain Barrier Partitioning Using the Electrotopological State , 2002, J. Chem. Inf. Comput. Sci..

[22]  Arun K Mandagere,et al.  Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.

[23]  Gabriele Cruciani,et al.  Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach. , 2005, Journal of medicinal chemistry.

[24]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[25]  Vladimir Poroikov,et al.  A New Statistical Approach to Predicting Aromatic Hydroxylation Sites. Comparison with Model-Based Approaches , 2004, J. Chem. Inf. Model..

[26]  Franco Lombardo,et al.  In silico ADME prediction: data, models, facts and myths. , 2003, Mini reviews in medicinal chemistry.

[27]  C. Beddell,et al.  Binding measurements of indolocarbazole derivatives to immobilised human serum albumin by high-performance liquid chromatography. , 1996, Journal of chromatography. B, Biomedical applications.

[28]  H. Kubinyi.  Variable Selection in QSAR Studies. II. A Highly Efficient Combination of Systematic Search and Evolution , 1994 .

[29]  Toshio Kinoshita,et al.  Prediction of human serum albumin–drug binding affinity without albumin , 2002 .

[30]  Hao Zhu,et al.  ESP: A Method To Predict Toxicity and Pharmacological Properties of Chemicals Using Multiple MCASE Databases , 2004, J. Chem. Inf. Model..

[31]  T. Kinoshita,et al.  Quantitative analysis of human serum albumin-drug interactions using reversed-phase and ion-exchange liquid chromatography , 1999 .

[32]  D. Agrafiotis,et al.  Variable selection for QSAR by artificial ant colony systems , 2002, SAR and QSAR in environmental research.

[33]  B Testa,et al.  Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.

[34]  Philip L. Smith,et al.  In vitro models to predict blood-brain barrier permeability , 1997 .

[35]  R. Kaliszan,et al.  Quantitative structure-retention relationships in affinity high-performance liquid chromatography. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[37]  Subhash C. Basak,et al.  Prediction of Cellular Toxicity of Halocarbons from Computed Chemodescriptors: A Hierarchical QSAR Approach , 2003, J. Chem. Inf. Comput. Sci..

[38]  C. Decker,et al.  Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. , 2001, Current opinion in chemical biology.

[39]  T. Hanai,et al.  Influence of glycosylation on the drug binding of human serum albumin. , 1998, Biomedical chromatography : BMC.

[40]  Anton J. Hopfinger,et al.  Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[41]  Dimitris K. Agrafiotis,et al.  A Novel Method for Building Regression Tree Models for QSAR Based on Artificial Ant Colony Systems , 2001, J. Chem. Inf. Comput. Sci..

[42]  S. Urien,et al.  Drug Binding in Plasma , 1994, Clinical pharmacokinetics.

[43]  John G. Topliss,et al.  QSAR Model for Drug Human Oral Bioavailability1 , 2000 .

[44]  Joseph V. Turner,et al.  Bioavailability Prediction Based on Molecular Structure for a Diverse Series of Drugs , 2004, Pharmaceutical Research.

[45]  D C Carter,et al.  Structure of human serum albumin. , 1990, Science.

[46]  Christopher Hulme,et al.  Knowledge-based approaches in the design and selection of compound libraries for drug discovery. , 2002, Current opinion in drug discovery & development.

[47]  M. Karelson.  Molecular descriptors in QSAR/QSPR , 2000 .

[48]  Ruisheng Zhang,et al.  QSAR Models for the Prediction of Binding Affinities to Human Serum Albumin Using the Heuristic Method and a Support Vector Machine , 2004, J. Chem. Inf. Model..

[49]  Han van de Waterbeemd,et al.  High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002 .

[50]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[51]  D C Carter,et al.  Three-dimensional structure of human serum albumin. , 1989, Science.

[52]  Hxugo Kubiny.  Variable Selection in QSAR Studies. I. An Evolutionary Algorithm , 1994 .

[53]  A J Hopfinger,et al.  Characterization of skin penetration processes of organic molecules using molecular similarity and QSAR analysis. , 2004, Molecular pharmaceutics.

[54]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[55]  T. Kennedy.  Managing the drug discovery/development interface , 1997 .

[56]  A. Cavalli,et al.  Stereoselective binding of 2,3-substituted 3-hydroxypropionic acids on an immobilised human serum albumin chiral stationary phase: stereochemical characterisation and quantitative structure-retention relationship study. , 2000, Journal of chromatography. A.

[57]  J. Lavandera,et al.  Cheminformatic models to predict binding affinities to human serum albumin. , 2001, Journal of medicinal chemistry.

[58]  Sandra Fox,et al.  High Throughput Screening for Drug Discovery: Continually Transitioning into New Technology , 1999, Journal of biomolecular screening.

[59]  G. Sudlow,et al.  Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.

[60]  Bruno Boulanger,et al.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery , 2002, J. Comput. Aided Mol. Des..

[61]  Lemont B. Kier,et al.  Modeling Drug Albumin Binding Affinity with E-State Topological Structure Representation , 2003, J. Chem. Inf. Comput. Sci..

[62]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors , 2003, J. Chem. Inf. Comput. Sci..

[63]  Luca Maria Gambardella,et al.  Ant Algorithms for Discrete Optimization , 1999, Artificial Life.

[64]  K M Merz,et al.  Molecular dynamics study of the IIA binding site in human serum albumin: influence of the protonation state of Lys195 and Lys199. , 2001, Journal of medicinal chemistry.

[65]  Michael C. Hutter,et al.  Prediction of blood–brain barrier permeation using quantum chemically derived information , 2003, J. Comput. Aided Mol. Des..

[66]  S. O'Brien,et al.  Greater than the sum of its parts: combining models for useful ADMET prediction. , 2005, Journal of medicinal chemistry.